Michael P Nghiem

Array ( [id] => 4035931 [patent_doc_number] => 05856305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Peptides endowed with antiinflammatory activity' [patent_app_type] => 1 [patent_app_number] => 8/836195 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2256 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856305.pdf [firstpage_image] =>[orig_patent_app_number] => 836195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045454 [patent_doc_number] => 05874544 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Antibodies to APO(A)' [patent_app_type] => 1 [patent_app_number] => 8/892544 [patent_app_country] => US [patent_app_date] => 1997-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 10429 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874544.pdf [firstpage_image] =>[orig_patent_app_number] => 892544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963551 [patent_doc_number] => 05885783 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Autoimmune inner ear disease antigen and diagnostic assay' [patent_app_type] => 1 [patent_app_number] => 8/886751 [patent_app_country] => US [patent_app_date] => 1997-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6334 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885783.pdf [firstpage_image] =>[orig_patent_app_number] => 886751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411541 [patent_doc_number] => 06310195 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Nucleic acid encoding a lectin-derived progenitor cell preservation factor' [patent_app_type] => 1 [patent_app_number] => 8/881189 [patent_app_country] => US [patent_app_date] => 1997-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 17089 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310195.pdf [firstpage_image] =>[orig_patent_app_number] => 881189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032706 [patent_doc_number] => 05942405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Therapeutic and screening methods using C3a receptor and C3a' [patent_app_type] => 1 [patent_app_number] => 8/876874 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 22820 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942405.pdf [firstpage_image] =>[orig_patent_app_number] => 876874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044750 [patent_doc_number] => 05869259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Carboxypeptidase inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/871033 [patent_app_country] => US [patent_app_date] => 1997-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 19458 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869259.pdf [firstpage_image] =>[orig_patent_app_number] => 871033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002640 [patent_doc_number] => 05858975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Oxyntomodulin peptide having cardiotonic activity and insulin release-bromating activity' [patent_app_type] => 1 [patent_app_number] => 8/836528 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3909 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858975.pdf [firstpage_image] =>[orig_patent_app_number] => 836528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031323 [patent_doc_number] => 05994311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Cell adhesion peptides for modifying the adhesion capacity of eukaryotic cells between each other' [patent_app_type] => 1 [patent_app_number] => 8/793264 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11867 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994311.pdf [firstpage_image] =>[orig_patent_app_number] => 793264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805591 [patent_doc_number] => 05854069 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'GD2 anti-idiotypic antibodies and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/844073 [patent_app_country] => US [patent_app_date] => 1997-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 4999 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854069.pdf [firstpage_image] =>[orig_patent_app_number] => 844073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4351574 [patent_doc_number] => 06218103 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Herpes simplex virus US3 and ICP4 as inhibitors of apoptosis' [patent_app_type] => 1 [patent_app_number] => 8/843659 [patent_app_country] => US [patent_app_date] => 1997-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21752 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218103.pdf [firstpage_image] =>[orig_patent_app_number] => 843659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126154 [patent_doc_number] => 06146631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Immunotoxins comprising ribosome-inactivating proteins' [patent_app_type] => 1 [patent_app_number] => 8/839765 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 14 [patent_no_of_words] => 59044 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146631.pdf [firstpage_image] =>[orig_patent_app_number] => 839765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4170835 [patent_doc_number] => 06140305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Hereditary hemochromatosis gene products' [patent_app_type] => 1 [patent_app_number] => 8/834497 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 51762 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140305.pdf [firstpage_image] =>[orig_patent_app_number] => 834497 [rel_patent_id] =>[rel_patent_doc_number] =>)